Omid Salahi Ardekani received a BSc in Medical Laboratory Sciences in 2022 and an MSc in Medical Virology in 2026 from Shiraz University of Medical Sciences, Iran. He is currently a PhD student in Medical Virology at the Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. His work in medical virology has resulted in 25 scientific publications. He is a member of the American Society for Microbiology (ASM) and the Iranian Public Health Association. He also serves on the Reviewer Board of Virology Journal (ISSN:1743-422X). His research interests include emerging and re-emerging viral infections, immunology, and oncolytic virotherapy.
Omid Salahi Ardekani received a BSc in Medical Laboratory Sciences in 2022 and an MSc in Medical Virology in 2026 from Shiraz University of Medical Sciences, Iran. He is currently a PhD student in Medical Virology at the Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. His work in medical virology has resulted in 25 scientific publications. He is a member of the American Society for Microbiology (ASM) and the Iranian Public Health Association. He also serves on the Reviewer Board of Virology Journal (ISSN:1743-422X). His research interests include emerging and re-emerging viral infections, immunology, and oncolytic virotherapy.